Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.930
-0.070 (-2.33%)
Jun 23, 2025, 4:00 PM - Market closed

Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $40.52 million. The enterprise value is $18.38 million.

Market Cap 40.52M
Enterprise Value 18.38M

Important Dates

The last earnings date was Monday, June 23, 2025, before market open.

Earnings Date Jun 23, 2025
Ex-Dividend Date n/a

Share Statistics

GRCE has 13.83 million shares outstanding. The number of shares has increased by 27.10% in one year.

Current Share Class 13.72M
Shares Outstanding 13.83M
Shares Change (YoY) +27.10%
Shares Change (QoQ) +21.04%
Owned by Insiders (%) 18.50%
Owned by Institutions (%) 11.06%
Float 7.60M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.60
P/TBV Ratio 2.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.77

Current Ratio 11.77
Quick Ratio 11.53
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -14.91% and return on invested capital (ROIC) is -16.24%.

Return on Equity (ROE) -14.91%
Return on Assets (ROA) -14.35%
Return on Invested Capital (ROIC) -16.24%
Return on Capital Employed (ROCE) -23.81%
Revenue Per Employee n/a
Profits Per Employee -$299,000
Employee Count 32
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -3.20M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.91
52-Week Price Change n/a
50-Day Moving Average 2.71
200-Day Moving Average n/a
Relative Strength Index (RSI) 52.41
Average Volume (20 Days) 46,513

Short Selling Information

The latest short interest is 14,096, so 0.10% of the outstanding shares have been sold short.

Short Interest 14,096
Short Previous Month 15,134
Short % of Shares Out 0.10%
Short % of Float 0.19%
Short Ratio (days to cover) 0.42

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -16.68M
Pretax Income n/a
Net Income -9.57M
EBITDA -16.67M
EBIT -16.68M
Earnings Per Share (EPS) -$0.79
Full Income Statement

Balance Sheet

The company has $22.13 million in cash and n/a in debt, giving a net cash position of $22.13 million or $1.60 per share.

Cash & Cash Equivalents 22.13M
Total Debt n/a
Net Cash 22.13M
Net Cash Per Share $1.60
Equity (Book Value) 66.61M
Book Value Per Share 4.86
Working Capital 20.78M
Full Balance Sheet

Cash Flow

Operating Cash Flow -14.90M
Capital Expenditures n/a
Free Cash Flow -14.90M
FCF Per Share -$1.08
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.10%
Shareholder Yield -27.10%
Earnings Yield -23.61%
FCF Yield -36.78%

Analyst Forecast

The average price target for GRCE is $12.00, which is 309.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 309.56%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -5.20%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date Jul 10, 2023
Split Type Reverse
Split Ratio 0.1666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a